John R. Thomas
Professor of Law
Georgetown University Law Center
Click here for Professor Thomas' faculty listing
The End of Patent Medicines?
Exploring the Rise of Regulatory Exclusivities
Thursday, November 9, 2017
5:30 P.M. RECEPTION
6:15 P.M. LECTURE
The Houston Club
910 LOUISIANA – HOUSTON
To RSVP or for further information, contact
email@example.com or 713.743.2180
One Hour of CLE Credit
John R. (Jay) Thomas is Professor of Law at Georgetown University in Washington, D.C. Since 1999, he has served as a visiting scholar at the Congressional Research Service; he was also the inaugural Thomas Alva Edison Visiting Fellow at the United States Patent and Trademark Office. Jay previously served as law clerk to Chief Judge Helen Nies of the United States Court of Appeals for the Federal Circuit. He was a visiting researcher at the Institute of Intellectual Property in Tokyo, Japan and the Max Planck Institute in Munich, Germany, and has served on the law faculties of George Washington, Cornell, and the University of Tokyo. He is the author of the treatise Pharmaceutical Patent Law. He holds a B.S. in Computer Engineering from Carnegie Mellon, a J.D. from the University of Michigan, and an LL.M. from George Washington University.
Selected publications include: Pharmaceutical Patent Law (Arlington, Va.: Bloomberg BNA 3d ed. 2015); The End of "Patent Medicines"? Thoughts on the Rise of Regulatory Exclusivities, 70 Food & Drug L.J. 39-53 (2015); Toward a Theory of Regulatory Exclusivities, in Patent Law in Global Perspective 345-376 (Ruth L. Okediji & Margo A. Bagley eds., New York: Oxford University Press 2014); Authorized Generic Pharmaceuticals: Effects on Innovation, in Pharmaceutical Industry: Innovation and Developments 1-14 (David A. Mancuso & Isobel M. Grenada eds., Hauppauge, N.Y.: Nova Science Publishers 2011).
The End of Patent Medicines? Exploring the Rise of Regulatory Exclusivities
The phrase "patent medicine" is not heard much these days. The dubious cures so heavily employed prior to the enactment of the Federal Food, Drug, and Cosmetic Act have been regulated out of existence by the Food and Drug Administration. The same fate may await patented pharmaceuticals--at least to the extent that a proprietary right issued by the United States Patent and Trademark Office serves as the primary intellectual property driver of innovation in the field of health care. FDA-administered exclusivities--currently numbering fifteen, with serious proposals for new proprietary rights before the 115th Congress--may soon come to dominate patents. This talk will explore the substantial consequences of this trend for both public health and the intellectual property landscape.
2016 DANIEL C.K. CHOW, Frank E. and Virginia H. Bazler Chair in Business Law; The Ohio State University - Moritz College of Law
Trademark Squatting in China
2015 RUTH OKEDIJI, William L. Prosser Professor of Law; University of Minnesota Law School
Inventing Intellectual Property: Source Disclosure for Genetic Patent Rights?
2013 ELIZABETH A. ROWE, Research Foundation Professor of Law; Director, Program in Intellectual Property Law; Feldman Gale Term Professor in Intellectual Property Law; Levin College of Law, University of Florida
Intellectual Property and Information Control
2012 THE HONORABLE JIMMIE V. REYNA, Circuit Judge, United States Court of Appeals for the Federal Circuit
The U.S. Court of Appeals for the Federal Circuit: Immediate and Future Challenges Event Invitation
2011 ROBERT BRAUNEIS, Professor of Law; Co-Director of the Intellectual Property Law Program; Co-Director of the Dean Dinwoodey Center for Intellectual Property Studies; Member, Managing Board, Munich Intellectual Property Law Center, George Washington University Law School
Trademark Infringement, Dilution, and the Decline in Sharing of Famous Brand NamesEvent Invitation
2010 JANE K. WINN, Charles I. Stone Professor and Director, Shidler Center for Law Commerce & Technology, University of Washington School of Law
Information Security as a Governance Challenge Event Invitation
Event Invitation2009 GREGORY N. MANDEL, Professor of Law, Temple University Beasley School of Law
Patently Nonobvious: The Impact of Hindsight Bias on Patent Decisions
Event Invitation2008 MARGO A. BAGLEY, Professor of Law at the University of Virginia School of Law
Illegal, Immoral, Unethical… Patentable? Issues in the Early Lives of Inventions
2007 CLARISA LONG, Max Mendel Shaye Professor of Intellectual Property Law, Columbia University School of Law
The Political Economy of Intellectual Property LawEvent Invitation
2006 JOHN F. DUFFY, George Washington University Law School, Washington, D.C.
The Invention of Invention: A History of Nonobviousness Event Invitation
2005 DAN L. BURK, University of Minnesota Law School, Minneapolis
The Problem of Process in Biotechnology Event Invitation
2004 DAVID J. FRANKLYN, University of San Francisco School of Law
The Anti-Free Rider Principle in American Trademark Law Event Invitation
2003 WILLIAM F. LEE, Hale & Dorr LLP, Boston
Attorney-Client Privilege and Willful Infringement
2002 HON. PAUL MICHEL, U.S. Court of Appeals for the Federal Circuit, Washington, D.C.
Predicting the Scope of Patent Protection: Construing Literal Claim Scope and Determining Available Equivalents
2001 YSOLDE GENDREAU, Université de Montreal, Quebec
The Exportation of Copyright Models: The Retransmission Right and the Internet
2000 JERRE B. SWANN, Partner, Kilpatrick Stockton LLP, Atlanta
Trademark Dilution for the Year 2000
1999 JOSEPH STRAUS, Max Planck Institute for Foreign and International Patent, Copyright and Competition Law, Munich
Multinational Patent Enforcement: Problems and Solutions
1998 JOHN R. THOMAS, George Washington University Law School, Washington, D.C.
Transnational Patent Litigation
1997 HON. NANCY LINCK, Solicitor, U.S. Patent and Trademark Office, Washington, D.C.
Patent Prosecution for the New Millennium
1996 CHIEF CIRCUIT JUDGE GLENN ARCHER, CIRCUIT JUDGE PAULINE NEWMAN, AND SENIOR CIRCUIT JUDGE EDWARD SMITH, U.S. Court of Appeals for the Federal Circuit, Washington, D.C.
Perspectives on Patent Law from Three Federal Circuit Judges
1995 DONALD S. CHISUM, Author, CHISUM ON PATENTS
The Allocation of Decisional Responsibility Between Judge and Jury in Patent Trials
1994 JOHN PEGRAM, Davis, Hoxie, Faithfull & Hapgood LLP
Complexity and Cost in Patent Litigation